| Characteristic | BMS1 | BMS2 | SES | p Value |
| Cases | 7 | 6 | 10 | |
| Age (years) | 61.0 (10.49) | 64.2 (7.78) | 58.3 (9.82) | 0.50 |
| Time post-stenting (months) | 7.29 (2.06) | 44.50 (24.56) | 8.60 (2.72) | <0.0001* |
| Male sex | 6 | 6 | 8 | 0.51 |
| Stent diameter (mm) | 3.03 (0.34) | 3.04 (0.25) | 3.05 (0.28) | 0.99 |
| Stent length (mm) | 18.75 (3.77) | 17.50 (3.99) | 22.00 (6.03) | 0.15 |
| Hypertension | 5 | 6 | 8 | 0.38 |
| Diabetes mellitus | 1 | 2 | 6 | 0.16 |
| Smoking | 3 | 5 | 6 | 0.33 |
| CHO (mmol/l) | 4.33 (0.88) | 4.03 (0.36) | 4.51 (1.13) | 0.50 |
| TG (mmol/l) | 1.37 (0.52) | 2.08 (1.03) | 2.00 (1.53) | 0.77 |
| HDL (mmol/l) | 0.91 (0.43) | 1.04 (0.09) | 1.03 (0.22) | 0.80 |
| LDL (mmol/l) | 2.81 (0.69) | 2.35 (0.22) | 2.88 (0.97) | 0.39 |
| OCT target vessel | ||||
| LAD | 4 | 4 | 9 | 0.24 |
| LCX | 1 | 0 | 3 | |
| RCA | 2 | 2 | 0 |
BMS1 group, bare-metal stent with 5–10 months follow-up; BMS2 group, bare-metal stent with 23–93 months follow-up; SES group, sirloimus-eluting stent with 6–12 months of follow-up; cholesterol (CHO); triglyceride (TG); high-density lipoprotein cholesterol (HDL); low-density lipoprotein cholesterol (LDL); OCT, optical coherence tomography; left anterior descending artery (LAD); left circumflex artery (LCX); right coronary artery (RCA).*Within three groups, p<0.0001; BMS1 vs SES, p = NS.